DelNS1-nCoV-RBD LAIV

N/A

Report date: 2025/05/21 16:56:26

Base Information

Drug NameDelNS1-nCoV-RBD LAIV

Drug Alias NameDelNS1-nCoV-RBD LAIV

ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryHong Kong

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesThe University Of Hong Kong

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesThe University Of Hong Kong

Active IndicationsN/A

Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A